Ładowanie…
Każda spółka tutaj przepuszczona przez te same pięć testów wzrostu i generowania gotówki. To opisuje branżę tak, jak raportuje dziś — a nie którą z tych spółek kupić.
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | C | 50,4B USD | 43,21 USD | 100,49 | 17,2B USD | 2,9% |
| HLN | Haleon plc | B+ | 40,7B USD | 9,09 USD | 18,33 | 14,8B USD | 15,1% |
| ZTS | Zoetis Inc. | C+ | 33,5B USD | 82,57 USD | 13,92 | 9,5B USD | 26,4% |
| TAK | Takeda Pharmaceutical Company Limited | A | 33,5B USD | 20,86 USD | 48,79 | 29,8B USD | 0,9% |
| UTHR | United Therapeutics Corporation | C+ | 25,4B USD | 595,58 USD | 22,48 | 3,2B USD | 38,6% |
| VTRS | VIATRIS INC. | D | 24,1B USD | 21,06 USD | — | 14,7B USD | -23,9% |
| NBIX | NEUROCRINE BIOSCIENCES, INC. | A+ | 17,6B USD | 174,35 USD | 25,87 | 3,7B USD | 19,0% |
| ELAN | Elanco Animal Health Incorporated | A | 13,2B USD | 26,48 USD | — | 5,1B USD | -2,9% |
| RDY | DR. REDDY’S LABORATORIES LIMITED | B | 12,4B USD | 14,83 USD | 20,77 | 3,5B USD | 4,4% |
| KNSA | Kiniksa Pharmaceuticals International, plc | A+ | 8,1B USD | 95,80 USD | 73,13 | 946M USD | 11,6% |
| ALKS | Alkermes plc. | C | 8B USD | 47,88 USD | — | 1,8B USD | -0,0% |
| AMRX | Amneal Pharmaceuticals, Inc. | C | 7,6B USD | 21,72 USD | 51,71 | 3,2B USD | 4,2% |
| LNTH | LANTHEUS HOLDINGS, INC. | B+ | 6,6B USD | 101,58 USD | 25,08 | 1,6B USD | 17,3% |
| LQDA | LIQUIDIA CORPORATION | A | 5B USD | 55,19 USD | — | 621,9M USD | -15,1% |
| HIMS | HIMS & HERS HEALTH, INC. | C- | 4,9B USD | 20,81 USD | — | 2,9B USD | -6,7% |
| AMLX | Amylyx Pharmaceuticals, Inc. | D | 4,1B USD | 31,78 USD | — | 0,00 USD | — |
| BHC | Bausch Health Companies Inc. | A | 3,1B USD | 8,35 USD | — | 11,1B USD | -7,6% |
| XERS | XERIS BIOPHARMA HOLDINGS, INC. | F- | 3B USD | 16,51 USD | — | 368,3M USD | -1,8% |
| RGC | REGENCELL BIOSCIENCE HOLDINGS LIMITED | bez oceny | 2,7B USD | 5,45 USD | — | — | — |
| HCM | HutchMED (China) LIMITED | D | 2,6B USD | 15,04 USD | — | 549,1M USD | 3,3% |
| PRGO | Perrigo Company plc | F- | 2,3B USD | 16,56 USD | — | 4,1B USD | -43,3% |
| TRLV | TRULIEVE CANNABIS CORP. | F | 2,3B USD | 11,24 USD | — | 1,1B USD | -41,3% |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC. | C+ | 2,1B USD | 44,17 USD | 13,63 | 1,2B USD | 13,3% |
| ETON | ETON PHARMACEUTICALS, INC. | A+ | 2B USD | 68,42 USD | — | 141,1M USD | 35,3% |
| BCRX | BIOCRYST PHARMACEUTICALS, INC. | B | 2B USD | 7,65 USD | — | 961,5M USD | -37,4% |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | B | 1,7B USD | 29,42 USD | — | 865,1M USD | -5,1% |
| ANIP | ANI PHARMACEUTICALS, INC | B+ | 1,5B USD | 71,23 USD | 14,22 | 1B USD | 11,2% |
| ALVO | ALVOTECH | B | 1,5B USD | 4,93 USD | 49,25 | 586,3M USD | 4,8% |
| PCRX | PACIRA BIOSCIENCES, INC. | B | 1,5B USD | 36,47 USD | 39,22 | 743,3M USD | 5,1% |
| PAHC | Phibro Animal Health Corporation | B | 1,4B USD | 35,13 USD | 14,00 | 1,5B USD | 6,7% |
| CRON | CRONOS GROUP INC. | A | 1,3B USD | 3,46 USD | 20,32 | 206,2M USD | 28,0% |
| AMPH | Amphastar Pharmaceuticals, Inc. | B+ | 1,2B USD | 28,61 USD | 13,06 | 745,8M USD | 13,3% |
| HROW | Harrow, Inc. | D- | 1,1B USD | 29,30 USD | — | 303,3M USD | -9,4% |
| BGM | BGM Group Ltd | F- | 985,4M USD | 8,70 USD | — | 47,9M USD | -44,2% |
| IRWD | IRONWOOD PHARMACEUTICALS INC | C+ | 804,6M USD | 4,86 USD | 5,40 | 400,3M USD | 37,4% |
| COLL | Collegium Pharmaceutical, Inc. | B | 770,5M USD | 24,80 USD | 24,80 | 815,2M USD | 4,7% |
| TKNO | ALPHA TEKNOVA, INC. | B- | 541,6M USD | 8,61 USD | — | 46M USD | -34,8% |
| EOLS | EVOLUS, INC. | B | 492,1M USD | 7,44 USD | — | 325,5M USD | -9,6% |
| KMDA | KAMADA LTD | C+ | 469,6M USD | 8,14 USD | 18,93 | 196,9M USD | 13,6% |
| AQST | Aquestive Therapeutics, Inc. | D | 449,3M USD | 3,58 USD | — | 48,8M USD | -162,3% |
| TLRY | Tilray Brands, Inc. | C- | 385M USD | 2,61 USD | — | 963,1M USD | -17,1% |
| EBS | EMERGENT BIOSOLUTIONS INC. | D | 310,3M USD | 6,04 USD | — | 649,1M USD | -40,2% |
| EVO | Evotec SE | F- | 304,9M USD | 1,72 USD | — | 836,2M USD | -26,0% |
| ACB | AURORA CANNABIS INC | D- | 280,9M USD | 5,05 USD | 176,32 | 225,8M USD | -29,9% |
| BIOA | BIOAGE LABS, INC. | F- | 268,9M USD | 5,85 USD | — | 8,6M USD | -1253,6% |
| CGC | Canopy Growth Corporation | C- | 256,3M USD | 0,61 USD | — | 219,2M USD | -87,0% |
| LFCR | LIFECORE BIOMEDICAL, INC. | F | 242,4M USD | 6,40 USD | — | 128,9M USD | -30,0% |
| SIGA | Siga Technologies INC | F | 225,6M USD | 3,14 USD | — | 52,4M USD | 1,3% |
| INCR | INTERCURE LTD. | C- | 219,8M USD | 4,02 USD | — | 86,4M USD | -13,2% |
| ADCT | ADC Therapeutics SA | C | 203,6M USD | 1,60 USD | — | 84,9M USD | -95,7% |
| ANIK | Anika Therapeutics, Inc. | B- | 186,3M USD | 13,91 USD | — | 123,4M USD | -1,4% |
| GLAS | Glass House Brands Inc. | F- | 165,5M USD | 1,90 USD | — | 152,9M USD | -33,7% |
| AKBA | AKEBIA THERAPEUTICS, INC. | D | 158M USD | 0,57 USD | — | 197,2M USD | -22,6% |
| ORGO | ORGANOGENESIS HOLDINGS INC. | F- | 136,3M USD | 1,05 USD | — | 352M USD | -38,4% |
| DERM | Journey Medical Corp | C- | 125,7M USD | 4,46 USD | — | 68,2M USD | -9,0% |
| CRDL | Cardiol Therapeutics Inc. | bez oceny | 100,8M USD | 1,01 USD | — | — | — |
| CPIX | Cumberland Pharmaceuticals Inc. | F- | 94,8M USD | 6,33 USD | — | 39,9M USD | -27,4% |
| INM | INMED PHARMACEUTICALS INC. | F- | 85,5M USD | 15,56 USD | — | 4,5M USD | -292,1% |
| OGI | ORGANIGRAM HOLDINGS INC. | C- | 81,3M USD | 0,85 USD | — | 185,5M USD | -9,6% |
| ZYBT | Zhengye Biotechnology Holding Limited | D | 72,3M USD | 1,53 USD | — | 17,5M USD | -60,0% |
| CTOR | Citius Oncology, Inc. | bez oceny | 51,7M USD | 0,56 USD | — | — | — |
| SCYX | SCYNEXIS INC | F- | 34,1M USD | 3,43 USD | — | 18,9M USD | -53,5% |
| RMTI | ROCKWELL MEDICAL, INC. | B- | 28,7M USD | 7,13 USD | — | 72,6M USD | -7,8% |
| CPHI | CHINA PHARMA HOLDINGS, INC. | D- | 22,7M USD | 0,53 USD | — | 3,9M USD | -114,3% |
| TXMD | TherapeuticsMD, Inc. | F- | 21,4M USD | 1,85 USD | — | 3,3M USD | -6,6% |
| AYTU | AYTU BIOPHARMA, INC. | C | 19,7M USD | 1,82 USD | — | 57,6M USD | -24,8% |
| RDHL | REDHILL BIOPHARMA LTD. | F | 17,9M USD | 0,40 USD | — | -3,7M USD | -72,5% |
| TLPH | TALPHERA, INC. | D- | 15M USD | 1,05 USD | — | 1K USD | -1 465 800,0% |
| BFRI | Biofrontera Inc. | B- | 13,9M USD | 0,93 USD | — | 46,2M USD | -13,8% |
| SBFM | Sunshine Biopharma Inc. | D- | 10,7M USD | 2,76 USD | — | 35,3M USD | -16,5% |
| CABR | Caring Brands, Inc. | F- | 9,2M USD | 0,88 USD | — | 4,2K USD | -183 255,2% |
| IMCC | IM Cannabis Corp. | D | 7,2M USD | 0,56 USD | — | 32,8M USD | -40,1% |
| SNOA | SONOMA PHARMACEUTICALS, INC. | C- | 6,2M USD | 1,23 USD | — | 23,5M USD | -7,6% |
| SHPH | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | bez oceny | 5,4M USD | 5,32 USD | — | — | — |
| GELS | Gelteq Limited | D- | 4M USD | 0,43 USD | — | 116,4K USD | -4011,9% |
| APUS | APIMEDS PHARMACEUTICALS US, INC. | bez oceny | 3,4M USD | 2,28 USD | — | — | — |
| SXTC | China SXT Pharmaceuticals, Inc. | F- | 2,8M USD | 2,89 USD | — | 1,1M USD | -545,2% |
| YCBD | cbdMD, Inc. | D- | 1,6M USD | 0,39 USD | — | 20,9M USD | -13,8% |
| IXHL | Incannex Healthcare Inc. | F- | 993,5K USD | 1,98 USD | — | 0,00 USD | — |
| UPC | Universe Pharmaceuticals INC | D- | 907K USD | 1,61 USD | — | 17,9B USD | -20,6% |
| PRFX | PRF Technologies Ltd. | B- | 629,5K USD | 0,76 USD | — | 17K USD | -29 541,2% |
| AKAN | Akanda Corp. | F | 50,4K USD | 0,73 USD | — | 258,1K USD | -19 775,5% |
| INDV | Indivior Pharmaceuticals, Inc. | A | — | 28,15 USD | — | 1,4B USD | 32,8% |
| OPTH | Optimi Health Corp. | bez oceny | — | 2,19 USD | — | — | — |
Fundamenty z raportów do SEC, kursy z ostatniego przebiegu danych rynkowych. Sortuj po dowolnej kolumnie; spółki bez liczby lądują na końcu w obie strony.
Posortowane według kapitalizacji, od największej; kliknij dowolną kolumnę, żeby posortować inaczej. Spółki bez liczby lądują na końcu w obie strony, bo brak C/Z oznacza stratę, a nie okazję. Nic tutaj nie jest rekomendacją.